Page last updated: 2024-08-16

phenylephrine and Neurally Mediated Faint

phenylephrine has been researched along with Neurally Mediated Faint in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Medow, MS; Merchant, S; Stewart, JM; Suggs, M; Sutton, R; Terilli, C; Visintainer, P	1
Alembik, Y; Bousquet, P; Feingold, J; Feldman, J; Fischbach, M; Livolsi, A; Messer, J; Sharifah-Anion, IM; Weiss, L	1
Gasparini, G; Giada, F; Raviele, A	1
Akamine, Y; Aoyama, H; Ebuchi, T; Imai, S; Kanmatsuse, K; Kushiro, T; Matsudaira, K; Saito, F; Sugino, K; Suzuki, K; Takahashi, N; Takase, H; Tanaka, H; Tanaka, N; Yagi, H	1
Frenneaux, M; Thomson, HL; Wright, K	1
Becker, N; Koop, MR	1

Trials

1 trial(s) available for phenylephrine and Neurally Mediated Faint

Article	Year
Efficacy of a patient-activated pharmacologic pump using phenylephrine as active drug and prodromal symptoms as a marker of imminent loss of consciousness to abort tilt-induced syncope. Journal of the American College of Cardiology, 2005, Jan-18, Volume: 45, Issue:2 Topics: Female; Humans; Infusion Pumps, Implantable; Male; Middle Aged; Phenylephrine; Single-Blind Method; Syncope, Vasovagal; Tilt-Table Test; Vasoconstrictor Agents	2005

Article

Year

Efficacy of a patient-activated pharmacologic pump using phenylephrine as active drug and prodromal symptoms as a marker of imminent loss of consciousness to abort tilt-induced syncope.

Journal of the American College of Cardiology, 2005, Jan-18, Volume: 45, Issue:2

Topics: Female; Humans; Infusion Pumps, Implantable; Male; Middle Aged; Phenylephrine; Single-Blind Method; Syncope, Vasovagal; Tilt-Table Test; Vasoconstrictor Agents

2005

Other Studies

5 other study(ies) available for phenylephrine and Neurally Mediated Faint

Article	Year
Postsynaptic α1-Adrenergic Vasoconstriction Is Impaired in Young Patients With Vasovagal Syncope and Is Corrected by Nitric Oxide Synthase Inhibition. Circulation. Arrhythmia and electrophysiology, 2016, Volume: 9, Issue:8 Topics: Adolescent; Adult; Cardiac Output; Enzyme Inhibitors; Female; Heart Rate; Humans; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; Splanchnic Circulation; Syncope, Vasovagal; Treatment Outcome; Vascular Resistance; Vasoconstriction	2016
First model of spontaneous vagal hyperreactivity and its mode of genetic transmission. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Animals; Anti-Arrhythmia Agents; Atropine; Baroreflex; Blood Pressure; Crosses, Genetic; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Male; Phenylephrine; Pressoreceptors; Rabbits; Reflex, Abnormal; Sex Factors; Syncope, Vasovagal; Vagus Nerve	2002
Basic autonomic nervous function in patients with neurocardiogenic syncope. Clinical and experimental hypertension (New York, N.Y. : 1993), 2007, Volume: 29, Issue:3 Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Atropine; Blood Pressure; Female; Heart Rate; Humans; Infusions, Intravenous; Isoproterenol; Male; Middle Aged; Parasympathetic Nervous System; Parasympatholytics; Phentolamine; Phenylephrine; Propranolol; Severity of Illness Index; Sympathetic Nervous System; Syncope, Vasovagal	2007
Baroreflex sensitivity in patients with vasovagal syncope. Circulation, 1997, Jan-21, Volume: 95, Issue:2 Topics: Adult; Baroreflex; Carotid Arteries; Female; Hand Strength; Heart; Humans; Lung; Male; Middle Aged; Phenylephrine; Syncope, Vasovagal	1997
Prophylaxis of vasovagal reaction with Atrohist Plus. Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:7 Topics: Administration, Oral; Adult; Atropine; Chlorpheniramine; Drug Therapy, Combination; Humans; Male; Ophthalmic Solutions; Phenylephrine; Phenylpropanolamine; Scopolamine; Syncope, Vasovagal; Tablets; Tonometry, Ocular; Vasoconstrictor Agents	2001